[LABP] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 26.48%
YoY- -50.49%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 -18,000 0 18,000 -
PBT -5,232 -7,896 -11,284 -14,864 -20,097 -12,604 4,097 -
Tax -1,352 67 18 -89 320 191 -174 290.83%
NP -3,880 -7,963 -11,302 -14,775 -20,097 -12,604 4,097 -
Tax Rate - - - - - - 4.25% -
Total Cost 3,880 7,963 11,302 14,775 2,097 12,604 13,903 -57.19%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 111.65 0.00 22.76 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.96 -1.98 -2.81 -3.67 -5.20 -3.20 1.20 -
EPS Diluted -0.96 -1.98 -2.81 -3.67 -5.20 -3.20 1.20 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.